What does Highlight invest in?
Highlight invests most often at Series B and IPO (100% of the rounds on record).
United States · Investor
Filed with the SEC to raise a fund in Oct 2024. Last cheque observed Mar 2019.
QuietNew fund, Oct 2024Private equity
3 rounds on record
Mostly Series B and IPO: 100% of its rounds
Filed 1 private fund offerings with the SEC, the most recent in 2024-10From their own website
Every round we can evidence, newest first3 appearances
1 round
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Highlight invests most often at Series B and IPO (100% of the rounds on record).
3 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2019.
Its most recent investments on record: Imago BioSciences (Series B, Mar 2019), BrightGene (IPO, Jan 2018) and Bonti (Series B, Apr 2017).
The median round it joins is $40M.
No investments in the last 12 months; the latest was in Mar 2019.
Highlight is a private equity firm based in Y9, United States.
Its latest fund filing with the SEC was in Oct 2024.
From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it